• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Is sclerostin a true mediator of diabetic nephropathy, or just a surrogate of altered bone metabolism?

作者信息

Ahmad Malik Aqeel, Ibrahim Muhammad

机构信息

Faisalabad Medical University, Faisalabad, Pakistan.

Department of Medicine, Faisalabad Medical University, Faisalabad, Pakistan.

出版信息

Pediatr Nephrol. 2025 Oct;40(10):3327. doi: 10.1007/s00467-025-06870-7. Epub 2025 Jun 30.

DOI:10.1007/s00467-025-06870-7
PMID:40586786
Abstract
摘要

相似文献

1
Is sclerostin a true mediator of diabetic nephropathy, or just a surrogate of altered bone metabolism?硬化素是糖尿病肾病的真正介质，还是仅仅是骨代谢改变的一个替代指标？
Pediatr Nephrol. 2025 Oct;40(10):3327. doi: 10.1007/s00467-025-06870-7. Epub 2025 Jun 30.
2
Response to: "Is sclerostin a true mediator of diabetic nephropathy, or just a surrogate of altered bone metabolism?".回应：“硬化蛋白是糖尿病肾病的真正介质，还是仅仅是骨代谢改变的替代物？”
Pediatr Nephrol. 2025 Oct;40(10):3329-3330. doi: 10.1007/s00467-025-06925-9. Epub 2025 Aug 2.
3
Serum sclerostin as a marker of microvascular and macrovascular complications among children and adolescents with type 1 diabetes mellitus.血清硬化蛋白作为1型糖尿病儿童和青少年微血管及大血管并发症的标志物
Pediatr Nephrol. 2025 May 12. doi: 10.1007/s00467-025-06793-3.
4
A mechanism of action-reflective, dual cell-based bioassay for determining the bioactivity of sclerostin-neutralizing antibodies.一种基于作用机制反射的双细胞生物测定法，用于测定骨硬化蛋白中和抗体的生物活性。
SLAS Discov. 2024 Oct;29(7):100187. doi: 10.1016/j.slasd.2024.100187. Epub 2024 Oct 9.
5
Baicalin Nanocomplexes with an -Forming Biomimetic Gel Implant for Repair of Calvarial Bone Defects Localized Sclerostin Inhibition.具有α-形成仿生凝胶植入物的黄芩苷纳米复合物用于修复颅骨缺损 局部硬化蛋白抑制
ACS Appl Mater Interfaces. 2023 Feb 22;15(7):9044-9057. doi: 10.1021/acsami.2c20946. Epub 2023 Feb 8.
6
The Role of Sirtuins in Diabetic Nephropathy: A Comprehensive Review.沉默调节蛋白在糖尿病肾病中的作用：综述
Curr Protein Pept Sci. 2025;26(6):407-421. doi: 10.2174/0113892037340795241202044932.
7
Implementing Just Culture to Improve Patient Safety.实施公正文化以提高患者安全。
Mil Med. 2022 May 18. doi: 10.1093/milmed/usac115.
8
Molecular mechanisms underlying the effects of beta-sitosterol on TGF-β1/Nrf2/SIRT1/p53-mediated signaling in the kidney of a high-fat diet and sucrose-induced type-2 diabetic rat.β-谷甾醇对高脂饮食和蔗糖诱导的2型糖尿病大鼠肾脏中TGF-β1/Nrf2/SIRT1/p53介导信号传导影响的分子机制
Chem Biol Interact. 2025 Apr 25;411:111443. doi: 10.1016/j.cbi.2025.111443. Epub 2025 Feb 21.
9
Study on the modulation of kidney and liver function of rats with diabetic nephropathy by Huidouba through metabolomics.回豆巴通过代谢组学对糖尿病肾病大鼠肝肾功 能的调节作用研究
J Ethnopharmacol. 2025 Jun 11;351:120136. doi: 10.1016/j.jep.2025.120136.
10
The role of sclerostin in lipid and glucose metabolism disorders.骨硬化蛋白在脂代谢和糖代谢紊乱中的作用。
Biochem Pharmacol. 2023 Sep;215:115694. doi: 10.1016/j.bcp.2023.115694. Epub 2023 Jul 21.

本文引用的文献

1
Response to: "Is sclerostin a true mediator of diabetic nephropathy, or just a surrogate of altered bone metabolism?".回应：“硬化蛋白是糖尿病肾病的真正介质，还是仅仅是骨代谢改变的替代物？”
Pediatr Nephrol. 2025 Oct;40(10):3329-3330. doi: 10.1007/s00467-025-06925-9. Epub 2025 Aug 2.
2
Serum sclerostin as a marker of microvascular and macrovascular complications among children and adolescents with type 1 diabetes mellitus.血清硬化蛋白作为1型糖尿病儿童和青少年微血管及大血管并发症的标志物
Pediatr Nephrol. 2025 May 12. doi: 10.1007/s00467-025-06793-3.
3
Sclerostin and Vascular Pathophysiology.
骨硬化蛋白与血管病理生理学。
Int J Mol Sci. 2020 Jul 6;21(13):4779. doi: 10.3390/ijms21134779.
4
Intima media thickness measurement in children: A statement from the Association for European Paediatric Cardiology (AEPC) Working Group on Cardiovascular Prevention endorsed by the Association for European Paediatric Cardiology.儿童内膜中层厚度测量：欧洲儿科心脏病学会（AEPC）心血管预防工作组声明，经欧洲儿科心脏病学会认可
Atherosclerosis. 2015 Feb;238(2):380-7. doi: 10.1016/j.atherosclerosis.2014.12.029. Epub 2014 Dec 24.